BrainsWay to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
BrainsWay (NASDAQ & TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, has announced its upcoming virtual presentation at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference.
The presentation is scheduled for March 18, 2025, at 9:20 AM EST. Investors and interested parties can access the live webcast through the Events & News – Presentations section of BrainsWay's Investor Relations website. A replay of the presentation will remain available for 30 days after the broadcast. Individual meetings with management can be arranged through Oppenheimer & Co representatives.
BrainsWay (NASDAQ e TASE: BWAY), un leader globale nei trattamenti avanzati di neurostimolazione non invasiva per i disturbi mentali, ha annunciato la sua prossima presentazione virtuale alla 35ª Conferenza Annuale Oppenheimer sui Servizi MedTech e Healthcare.
La presentazione è programmata per il 18 marzo 2025, alle 9:20 AM EST. Gli investitori e le parti interessate possono accedere alla diretta attraverso la sezione Eventi & News – Presentazioni del sito web delle Relazioni con gli Investitori di BrainsWay. Una registrazione della presentazione sarà disponibile per 30 giorni dopo la trasmissione. Incontri individuali con la direzione possono essere organizzati tramite i rappresentanti di Oppenheimer & Co.
BrainsWay (NASDAQ y TASE: BWAY), un líder global en tratamientos avanzados de neuroestimulación no invasiva para trastornos de salud mental, ha anunciado su próxima presentación virtual en la 35ª Conferencia Anual de Servicios y Tecnología Médica de Oppenheimer.
La presentación está programada para el 18 de marzo de 2025, a las 9:20 AM EST. Los inversores y partes interesadas pueden acceder a la transmisión en vivo a través de la sección de Eventos y Noticias – Presentaciones en el sitio web de Relaciones con Inversores de BrainsWay. Una repetición de la presentación estará disponible durante 30 días después de la transmisión. Se pueden organizar reuniones individuales con la dirección a través de los representantes de Oppenheimer & Co.
브레인웨이 (NASDAQ 및 TASE: BWAY)는 정신 건강 장애를 위한 비침습적 신경 자극 치료의 글로벌 리더로, 오펜하이머 제35회 연례 헬스케어 메드텍 및 서비스 컨퍼런스에서의 가상 발표를 발표했습니다.
발표는 2025년 3월 18일 오전 9시 20분 EST로 예정되어 있습니다. 투자자 및 관심 있는 당사자는 브레인웨이 투자자 관계 웹사이트의 이벤트 및 뉴스 - 발표 섹션을 통해 실시간 웹캐스트에 접속할 수 있습니다. 발표의 재생은 방송 후 30일 동안 제공됩니다. 경영진과의 개별 회의는 오펜하이머 & Co. 대표를 통해 조정할 수 있습니다.
BrainsWay (NASDAQ et TASE : BWAY), un leader mondial dans les traitements avancés de neurostimulation non invasive pour les troubles de la santé mentale, a annoncé sa prochaine présentation virtuelle lors de la 35ème Conférence Annuelle Oppenheimer sur les Services et Technologies Médicales.
La présentation est prévue pour le 18 mars 2025 à 9h20 EST. Les investisseurs et les parties intéressées peuvent accéder au webinaire en direct via la section Événements & Actualités – Présentations du site des Relations Investisseurs de BrainsWay. Un replay de la présentation sera disponible pendant 30 jours après la diffusion. Des réunions individuelles avec la direction peuvent être organisées par l'intermédiaire des représentants d'Oppenheimer & Co.
BrainsWay (NASDAQ & TASE: BWAY), ein globaler Marktführer in fortschrittlichen nicht-invasiven Neurostimulationsbehandlungen für psychische Gesundheitsstörungen, hat seine bevorstehende virtuelle Präsentation auf der 35. jährlichen Oppenheimer-Konferenz für Gesundheits- und Medizintechnologie angekündigt.
Die Präsentation ist für den 18. März 2025 um 9:20 Uhr EST geplant. Investoren und Interessierte können über den Bereich Veranstaltungen & Nachrichten – Präsentationen auf der Investor-Relations-Website von BrainsWay auf den Live-Stream zugreifen. Eine Aufzeichnung der Präsentation bleibt 30 Tage nach der Übertragung verfügbar. Einzelgespräche mit dem Management können über die Vertreter von Oppenheimer & Co. arrangiert werden.
- None.
- None.
BURLINGTON, Mass. and JERUSALEM, March 04, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that management will present virtually at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference at 9:20 AM EST on March 18, 2025.
A live webcast of the presentation will be available on the Events & News – Presentations page of the Company's Investor Relations website. An archived replay of the presentation will be available on the Company's website for 30 days following the live broadcast.
Please contact your representative at Oppenheimer & Co to request a 1-on-1 meeting around the conference.
About BrainsWay
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with operations in Israel and the U.S., BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.
Contacts:
BrainsWay:
Ido Marom
Chief Financial Officer
Ido.Marom@BrainsWay.com
Investors:
Brian Ritchie
LifeSci Advisors
britchie@lifesciadvisors.com
FAQ
When is BrainsWay (BWAY) presenting at the Oppenheimer Healthcare Conference 2025?
How long will the BWAY Oppenheimer Conference presentation replay be available?
Where can investors watch BrainsWay's (BWAY) Oppenheimer Conference presentation?
How can investors schedule a meeting with BWAY management during the Oppenheimer Conference?
